Bridging the gap between anatomy and molecular genetics for an improved understanding of congenital heart disease

Annals of Anatomy

Volumn 188, Issue 3, 2006, Pages 213-220

  Reamon Buettner, Stella Marie ^a   Spanel Borowski, Katharina ^b   Borlak, Jürgen ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Anatomy; Congenital heart disease; Molecular genetics

Indexed keywords

FORMALDEHYDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4;

ARTICLE; CONGENITAL HEART DISEASE; FREQUENCY ANALYSIS; GENETIC ANALYSIS; HEART DEVELOPMENT; HUMAN; HYPOTHESIS; MOLECULAR GENETICS; MOLECULAR MECHANICS; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PATHOLOGICAL ANATOMY; SOMATIC MUTATION; TISSUE PREPARATION;

ANIMALIA;

EID: 33646548928     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2005.10.007     Document Type: Article

References (60)

1. Botto, L.D., Correa, A., 2003. Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Prog. Pediatr. Cardiol. 18, 111-121.
2. Bruneau, B.G., 2002. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ. Res. 90, 509-519.
3. Bruneau, B.G., Nemer, G., Schmitt, J.P., Charron, F., Robitallie, L., Caron, S., Conner, D.A., Gessler, M., Nemer, M., Seidman, C.E., Seidman, J.G., 2001. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106, 709-721.
4. Ching, Y.H., Ghosh, TK., Cross, S.J., Packham, E.A., Honeyman, L., Loughna, S., Robinson, T.E., Dearlove, A.M., Ribas, G., Bonser, A.J., Thomas, N.R., Scotter, A.J., Caves, L.S., Tyrrell, G.P, Newbury-Ecob, R.A., Munnich, A., Bonnet, D., Brook, J.D., 2005. Mutation in myosin heavy chain 6 causes atrial septal. defect. Nat. Genet. 37, 423-428.
5. Craatz, S., Kunzel, E., Spanel-Borowski, K., 2002. Classification of a collection of malformed human hearts: practical experience in the use of sequential segmental analysis. Pediatr. Cardiol. 23, 483-490.
6. Craatz, S., Kunzel, E., Spanel-Borowski, K., 2003. Right-sided aortic arch and tetralogy of Fallot in humans - a morphological study of 10 cases. Cardiovasc. Pathol. 12, 226-232.
7. Dai, Y.S., Cserjesi, P., Markham, B.E., Molkentin, J.D., 2002. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J. Biol. Chem. 277, 24390-24398.
8. Donovan, J., Kordylewska, A., Jan, Y.N., Utset, M.F., 2002. Tetralogy of Fallot and other congenital heart defects in Hey2 mutant mice. Curr. Biol. 12, 1605-1610.
9. Durocher, D., Nemer, M., 1998. Combinatorial interactions regulating cardiac transcription. Dev. Genet. 22, 250-262.
10. Elliott, D.A., Kirk, E.O., Yeoh, T., Chandar, S., McKenzie, F., Taylor, P., Grossfeld, P., Fatkin, D., Jones, O., Hayes, P., Feneley, M., Harvey, R.P., 2003. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J. Am. Coll. Cardiol. 41, 2072-2076.
11. Erickson, R.P., 2003. Somatic gene mutation and human disease other than cancer. Mutat. Res. 543, 125-136.
12. Fischer, A., Klamt, B., Schumacher, N., Glaeser, C., Hansmann, I., Fenge, H., Gessler, M., 2004. Phenotypic variability in Hey2 -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm. Genome 15, 711-716.
13. Franco, D., Campione, M., 2003. The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends. Cardiovasc. Med. 13, 157-163.
14. Garg, V., Kathiriya, I.S., Barnes, R., Schluterman, M.K., King, I.N., Butler, C.A., Rothrock, C.R., Eapen, R.S., Hirayama-Yamada, K., Joo, K., Matsuoka, R., Cohen, J.C., Srivastava, D., 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443-447.
15. Gessler, M., Knobeloch, K.P., Helisch, A., Amann, K., Schumacher, N., Rohde, E., Fischer, A., Leimeister, C., 2002. Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2-/-mice. Curr. Biol. 12, 1601-1604.
16. Gruber, P.J., Epstein, J.A., 2004. Development gone awry: congenital heart disease. Circ. Res. 94, 273-283.
17. Harvey, R.P., 2002. Patterning the vertebrate heart. Nat. Rev. Genet. 3, 544-556.
18. Harvey, R.P., Lai, D., Elliott, D., Biben, C., Solloway, M., Prall, O., Stennard, F., Schindeler, A., Groves, N., Lavulo, L., Hyun, C., Yeoh, T., Costa, M., Furtado, M., Kirk, E., 2002. Homeodomain factor Nkx2-5 in heart development and disease. Cold Spring Harb. Symp. Quant. Biol. 67, 107-114.
19. Heathcote, K., Braybrook, C., Abushaban, L., Guy, M., Khetyar, M.E., Patton, M.A., Carter, N.D., Scambler, P.J., Syrris, P., 2005. Common arterial trunk associated with a homeodomain mutation of NKX2.6. Hum. Mol. Genet. 14, 585-593.
20. Heinritz, W., Moschik, A., Kujat, A., Spranger, S., Heilbronner, H., Demuth, S., Bier, A., Tihanyi, M., Mundlos, S., Gruenauer-Kloevekorn, C., Froster, U.G., 2005. Identification of new mutations in the TBX5 gene in patients with Holt-Oram syndrome. Heart 91, 383-384.
21. Hirayama-Yamada, K., Kamisago, M., Akimoto, K., Aotsuka, H., Nakamura, Y., Tomita, H., Furutani, M., Imamura, S. I., Takao, A., Nakazawa, M., Matsuoka, R., 2005. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am. J. Med. Genet. A. 135, 47-52.
22. Hiroi, Y., Kudoh, S., Monzen, K., Ikeda, Y., Yazaki, Y., Nagai, R., Komuro, I., 2001. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat. Genet. 28, 276-280.
23. Hobbs, C.A., Cleves, M.A., Keith, C., Ghaffar, S., James, S.J., 2005. NKX2.5 and congenital heart defects: a population-based study. Am. J. Med. Genet. A. 134, 223-225.
24. Hoffman, J.I., Kaplan, S., 2002. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890-1900.
25. Holzelova, E., Vonarbourg, C., Stolzenberg, M.C., Arkwright, P.D., Selz, F., Prieur, A.M., Blanche, S., Bartunkova, J., Vilmer, E., Fischer, A., Le Deist, F., Rieux-Laucat, F., 2004. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N. Engl. J. Med. 351, 1409-1418.
26. Horb, M.E., Thomsen, G.H., 1999. Tbx5 is essential for heart development. Development 126, 1739-1751.
27. Inga, A., Reamon-Buettner, S.M., Borlak, J., Resnick, M.A., 2005. Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Hum. Mol. Genet. 14, 1965-1975.
28. Jay, P.Y., Harris, B.S., Buerger, A., Rozhitskaya, O., Maguire, C.T., Barbosky, L.A., McCusty, E., Berul, C.I., O'Brien, T.X., Gourdie, R.G., Izumo, S., 2004. Function follows form: cardiac conduction system defects in Nkx2-5 mutation. Anat. Rec. 280A, 966-972.
29. Kasahara, H., Benson, D.W., 2004. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc. Res. 64, 40-51.
30. Lee, Y., Shioi, T., Kasahara, H., Jobe, S.M., Wiese, R.J., Markham, B.E., Izumo, S., 1998. The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol. Cell. Biol. 18, 3120-3129.
31. McElhinney, D.B., Geiger, E., Blinder, J., Woodrow, B.D., Goldmuntz, E., 2003. NKX2.5 mutations in patients with congenital heart disease. J. Am. Coll. Cardiol. 42, 1650-1655.
32. Molkentin, J.D., 2000. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 275, 38949-38952.
33. Mori, A.D., Bruneau, B.G., 2004. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr. Opin. Cardiol. 19, 211-215.
34. Morin, S., Charron, F., Robitaille, L., Nemer, M., 2000. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J 19, 2046-2055.
35. Morin, S., Pozzulo, G., Robitaille, L., Cross, J., Nemer, M., 2005. MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters. J Biol. Chem. 280, 32272-32278.
36. Muncke, N., Niesler, B., Roeth, R., Schon, K., Rudiger, H.J., Goldmuntz, E., Goodship, J., Rappold, G., 2005. Mutational analysis of the PITX2 coding region revealed no common cause for transposition of the great arteries (dTGA). BMC. Med. Genet. 6, 20.
37. Nemer, G., Nemer, M., 2001. Regulation of heart development and function through combinatorial interactions of transcription factors. Ann. Med. 33, 604-610.
38. Okubo, A., Miyoshi, O., Baba, K., Takagi, M., Tsukamoto, K., Kinoshita, A., Yoshiura, K., Kishino, T., Ohta, T, Niikawa, N., Matsumoto, N., 2004. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J. Med. Genet. 41, e97.
39. Pashmforoush, M., Lu, J.T., Chen, H., Amand, T.S., Kondo, R., Pradervand, S., Evans, S.M., Clark, B., Feramisco, J.R., Giles, W., Ho, S.Y., Benson, D.W., Silberbach, M., Shou, W., Chien, K.R., 2004. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117, 373-386.
40. Pikkarainen, S., Tokola, H., Kerkela, R., Ruskoaho, H., 2004. GATA transcription factors in the developing and adult heart. Cardiovasc. Res. 63, 196-207.
41. Pu, W.T., Ishiwata, T., Juraszek, A.L., Ma, Q., Izumo, S., 2004. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev. Biol. 275, 235-244.
42. Puck, J.M., Straus, S.E., 2004. Somatic mutations - not just for cancer anymore. N. Engl. J. Med. 351, 1388-1390.
43. Reamon-Buettner, S.M., Borlak, J., 2004a. Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J. Med. Genet. 41, 684-690.
44. Reamon-Buettner, S.M., Borlak, J., 2004b. TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts. Hum. Mutat. 24, 104.
45. Reamon-Buettner, S.M., Borlak, J., 2005a. GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart. J. Med. Genet. 42, e32.
46. Reamon-Buettner, S.M., Borlak, J., 2005b. Genetic analysis of cardiac specific transcription factors reveals novel insights into the molecular causes of congential heart disease. Future Cardiol. 1, 355-361.
47. Reamon-Buettner, S.M., Borlak, J., 2005c. HEY2 mutations in malformed hearts. Hum. Mutat. 27, 118.
48. Reamon-Buettner, S.M., Hecker, H., Spanel-Borowski, K., Craatz, S., Kuenzel, E., Borlak, J., 2004. Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations. Am. J. Pathol. 164, 2117-2125.
49. Sakata, Y., Kamei, C.N., Nakagami, H., Bronson, R., Liao, J.K., Chin, M.T., 2002. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc. Natl. Acad. Sci. USA 99, 16197-16202.
50. Sarkozy, A., Conti, E., D'Agostino, R., Digilio, M.C., Formigari, R., Picchio, F., Marino, B., Pizzuti, A., Dallapiccola, B., 2005a. ZFPM2/ FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia. Am. J. Med. Genet. A 133, 68-70.
51. Sarkozy, A., Conti, E., Neri, C., D'Agostino, R., Digilio, M.C., Esposito, G., Toscano, A., Marino, B., Pizzuti, A., Dallapiccola, B., 2005b. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J. Med.Genet. 42, e16.
52. Sepulveda, J.L., Vlahopoulos, S., Iyer, D., Belaguli, N., Schwartz, R.J., 2002. Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J. Biol. Chem. 277, 25775-25782.
53. Shiojima, I., Komuro, I., Oka, T., Hiroi, Y., Mizuno, T., Takimoto, E., Monzen, K., Aikawa, R., Akazawa, H., Yamazaki, T., Kudoh, S., Yazaki, Y., 1999. Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J. Biol. Chem. 274, 8231-8239.
54. Sun, X., Frierson, H.F., Chen, C., Li, C., Ran, Q., Otto, K.B., Cantarel, B.L., Vessella, R.L., Gao, A.C., Petros, J., Miura, Y., Simons, J.W., Dong, J.T., 2005. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat. Genet. 37, 407-412.
55. Takeuchi, J.K., Ohgi, M., Koshiba-Takeuchi, K., Shiratori, H., Sakaki, I., Ogura, K., Saijoh, Y., Ogura, T., 2003. Tbx5 specifies the left/ right ventricles and ventricular septum position during cardiogenesis. Development 130, 5953-5964.
56. Weismann, C.G., Hager, A., Kaemmerer, H., Masten, C.L., Morris, C.D., Schranz, D., Kreuder, J., Gelb, B.D., 2005. PTPN11 mutations play a minor role in isolated congenital heart disease. Am. J. Med. Genet. A. 136, 146-151.
57. Weiss, K.M., 2005. Cryptic causation of human disease: reading between the (germ) lines. Trends Genet. 21, 82-88.
58. Zeisberg, E.M., Ma, Q., Juraszek, A.L., Moses, K., Schwartz, R.J., Izumo, S., Pu, W.T, 2005. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J. Clin. Invest. 115, 1522-1531.
59. Zhong, T.P., Rosenberg, M., Mohideen, M.A., Weinstein, B., Fishman, M.C., 2000. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824.
60. Zhong, T.P., Childs, S., Leu, J.P, Fishman, M.C., 2001. Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220.